Standardized diagnosis and treatment for endocrine hypertension
Standardized Diagnosis and Treatment of Endocrine Hypertension
This study is testing how different treatments for endocrine hypertension affect patients' health over a year, looking at things like their metabolism, mental health, and heart risks.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Affiliated Hospital of Nantong University Academic / other |
| Locations | 1 site (Nantong, Jiangsu) |
| Trial ID | NCT05149781 on ClinicalTrials.gov |
What this trial studies
This study collects data from patients with endocrine hypertension and primary hypertension who have provided informed consent. Patients will be categorized into surgical and drug treatment groups based on their actual treatment. A comprehensive database will be established to evaluate various health indicators, including metabolic and biochemical markers, psychological status, and cardiovascular risk factors. Participants will be followed for 12 months, with assessments at baseline, 6 months, and 12 months to monitor their health outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 years and older diagnosed with endocrine hypertension.
Not a fit: Patients with a history of myocardial infarction, congestive heart failure, or stroke may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and treatment strategies for patients with endocrine hypertension.
How similar studies have performed: While similar studies have explored hypertension treatment, this approach focuses specifically on endocrine hypertension, making it a novel investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: age≥18 years Exclusion Criteria: 1. myocardial infarction 2. congestive heart failure 3. stroke
Where this trial is running
Nantong, Jiangsu
- Gu Yunjuan — Nantong, Jiangsu, China (Recruiting)
Study contacts
- Principal investigator: Gu Yunjuan, M.D/Ph.D — Affiliated Hospital of Nantong University
- Study coordinator: Gu Yunjuan, M.D/Ph.D
- Email: desette@ntu.edu.cn
- Phone: +8615851207860
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.